RTI Surgical has announced that Brian K Hutchison has is to retire from his position as president and chief executive officer of the company, and step down from the board of directors. Hutchison has agreed to remain in his current roles to assist the RTI board and management team with an orderly transition. RTI’s board is commencing a search for the chief executive officer position.
“We have asked Brian to remain with us to ensure an orderly transition to a new CEO,” says RTI chairman Curtis M Selquist.
Hutchison joined RTI as president and chief executive officer in 2001, and oversaw its growth from a small tissue bank in Florida to a global player in biologics-based implants. Over the past 15 years, the company has expanded its product portfolio significantly from a few allograft implants used in spinal and orthopaedic applications to a multifaceted portfolio of biologic, metals and synthetic products used in a wide array of surgical applications. Today, RTI has more than 1,100 employees and four manufacturing facilities dedicated to helping patients worldwide.
